Net profit of Aurobindo Pharma rose 7.62% to Rs 910.29 crore in the quarter ended December 2025 as against Rs 845.81 crore during the previous quarter ended December 2024. Sales rose 9.01% to Rs 8604.51 crore in the quarter ended December 2025 as against Rs 7893.15 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales8604.517893.15 9 OPM %20.6119.99 - PBDT1868.581618.38 15 PBT1403.851199.85 17 NP910.29845.81 8 Powered by Capital Market - Live News

The board of Aurobindo Pharma at its meeting held on 09 February 2026 has approved a proposal to file a scheme of amalgamation for merger of Auro Vaccines, a wholly owned step-down subsidiary of the Company with Curateq Biologics, a wholly owned subsidiary of the Company, with Hon`ble NCLT, Hyderabad. Powered by Capital Market - Live News

The board of Aurobindo Pharma at its meeting held on 09 February 2026 has approved to enter into a power purchase agreement with Garuda Renewables, to procure renewable energy from hybrid sources of wind and solar and in this connection the Company will be investing Rs. 66 crores for acquiring upto 26% stake in Garuda Renewables. Powered by Capital Market - Live News

The board of Aurobindo Pharma at its meeting held on 09 February 2026 has approved the appointment of Dr. Punita Kumar Sinha (DIN: 05229262) as Additional Director designated as Non-Executive Independent Director for a term of 3 (Three) years with effect from 09 February 2026. Powered by Capital Market - Live News

Aurobindo Pharma announced that the United States Food and Drug Administration (US FDA) inspected Unit-III, a Formulation manufacturing facility, of Eugia Pharma Specialities, a wholly owned subsidiary of the Company, situated at Phase-III, TSIIC, EPIP, IDA, Pashamylaram, Patancheru Revenue Mandal, Sangareddy District, 502307, Telangana, from 27 January to 06 February 2026. The inspection concluded with 11 observations. The observations are procedural in nature and will be responded to within the stipulated time. Powered by Capital Market - Live News